Vascular Biogenics Ltd. VBLT
Set alert
0.16 0.00 0.00%
At close · Oct 16
0.1526 Day range 0.1925
0.1009 52-week range 0.32
- Open
- 0.1734
- Prev close
- 0.156
- Mkt cap
- 12.11M
- Vol
- 5.38M
- Avg vol
- 787.72K
- EPS
- -0.18
- P/E
- -0.87
- Div yield
- 0.00%
More statistics
- Low
- 0.1526
- High
- 0.1925
- Forward P/E
- -0.26
- Beta
- 0.71
- Short ratio
- 0.55
- Inst. own
- 14.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2023
- 50-d avg
- 0.228423
- 200-d avg
- 0.206284
- 1y target
- 0.00
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 2
- 2 months ago 2
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.12 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.13 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.92M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2022 | Chardan Capital | Downgrade | Buy | Neutral |
| Jul 19, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 27, 2022 | Chardan Capital | Initiated | — | Buy |
| Jun 2, 2021 | Roth Capital | Maintained | — | Buy |
| Jan 27, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 16, 2020 | Oppenheimer | Maintained | — | Outperform |
| Jun 26, 2019 | Oppenheimer | Initiated | — | Outperform |
| Oct 14, 2018 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Mar 8, 2018 | Chardan Capital | Downgrade | Buy | Neutral |
| Mar 7, 2018 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 27, 2017 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jun 27, 2016 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 8, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Nov 8, 2015 | Piper Sandler | Initiated | — | Overweight |
| Sep 20, 2015 | Chardan Capital | Initiated | — | Buy |
| May 21, 2015 | Roth Capital | Initiated | — | Buy |
| Feb 16, 2015 | Oppenheimer | Downgrade | Outperform | Perform |
| Feb 16, 2015 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Jan 21, 2015 | Deutsche Bank | Maintained | — | Buy |